Hybrid bimetallic plasma array and preparation method thereof, and plasma array assisted laser desorption ionization mass spectrometry detection method and application thereof

The plasma array formed by self-assembly of mixed bimetallic plasma arrays is used as MALDI MS matrix material, which solves the accurate quantification problem of quantitative detection of nucleoside substances, and achieves fast, accurate, low-cost high-throughput detection, suitable for complex Clinical sample.

CN117686476BActive Publication Date: 2024-11-12SHANGHAI CHEST HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311708780.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-13
Publication Date
2024-11-12
Estimated Expiration
2043-12-13

AI Technical Summary

Technical Problem

It is difficult to accurately detect nucleoside substances in the prior art. Traditional chromatography and enzyme-linked immunosorbent assays have problems such as long detection time, high cost and strong background noise, especially in low-quality areas, high-throughput detection is difficult to achieve.

Method used

The hybrid bimetallic plasma array is used to form a plasma array by self-assembly, as the matrix material of MALDI MS, and self-assembled with liquid-liquid interface or oil-water-oil three-phase interface to enhance the binding affinity of chemical groups and be used for nucleosides. Quantitative detection of substances.

Benefits of technology

It realizes fast, accurate, low-cost and high-throughput detection of nucleoside substances, and has the characteristics of simple operation and high sensitivity, and is suitable for the detection of complex clinical samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117686476B_ABST
    Figure CN117686476B_ABST
Patent Text Reader

Abstract

The present invention relates to a quantitative detection technology, and specifically to a hybrid bimetallic plasma array and a preparation method, and a detection method and application of a plasma array assisted laser desorption ionization mass spectrometry, wherein the plasma array is obtained by self-assembly of positively charged noble metal nanoparticles and negatively charged noble metal nanoparticles, wherein the positively charged noble metal nanoparticles and the negatively charged noble metal nanoparticles are nanoparticles of different noble metals; or, at least the positively charged noble metal nanoparticles are bi-noble metal nanoparticles; or, at least the negatively charged noble metal nanoparticles are bi-noble metal nanoparticles. Compared with the prior art, the present invention solves the problem that both chromatography and enzyme-linked immunosorbent assay in the prior art are difficult to accurately and quantitatively detect nucleoside substances, and that MALDI MS has strong background noise in the low-mass region, resulting in inaccurate detection, thereby realizing rapid and selective identification of specific molecules, and obtaining the signal intensity of specific molecules through fingerprints.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a quantitative detection technique, in particular to a hybrid bimetallic plasma array and a preparation method thereof, and a detection method and application of a plasma array-assisted laser desorption ionization mass spectrometry. Background Art

[0002] Metabolites are located at the end of biochemical pathways and provide functional fingerprints of the physiological and pathophysiological states of the body. Disease-related processes, such as tumor development, drug resistance, immune response, and pluripotency maintenance, are regulated by coordinated changes in metabolic enzymes and transporters and their corresponding metabolites. Therefore, the detection of metabolic molecules is of great significance in disease diagnosis, treatment, and other aspects.

[0003] The preferential and quantitative detection of conventional metabolites mainly relies on gas / liquid chromatography and mass spectrometry (GC / LC-MS). Both of these methods require cumbersome sample pretreatment and additional chromatographic separation running times (~40 minutes) to process clinical samples to address the compositional complexity of clinical samples and the trace abundance of target metabolites. Therefore, establishing an accurate and rapid quantitative analysis method to monitor metabolites in biological samples used clinically remains a major challenge.

[0004] Matrix-assisted laser desorption / ionization mass spectrometry (MALDI MS) can rapidly, sensitively, and high-throughput detect metabolite molecules in a small amount of sample (~nL) with little or only simple sample pretreatment with the assistance of a matrix. However, traditional organic matrices (such as α-cyano-4-hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic acid (DHB)) have strong background noise in the low mass region (<m / z 700) due to self-dissociation, which hinders their application in metabolite detection.

[0005] In summary, the current quantitative detection of metabolites mainly relies on chromatography and enzyme-linked immunosorbent assay: 1) For chromatography, complex samples need to be pretreated, and there are problems such as long detection time and high cost, making it difficult to achieve low-cost and high-throughput detection of actual complex samples and difficult to be used clinically. 2) For enzyme-linked immunosorbent assay, the detection time is long and the antibodies are expensive, making it difficult to achieve high-throughput and low-cost detection of clinical complex samples. In addition, nucleoside substances have problems such as short half-lives (e.g., the half-life of adenosine is extremely short ~ several seconds), and accurate quantitative detection cannot be achieved relying on conventional chromatography and enzyme-linked immunosorbent assay. Therefore, a method for preferential and quantitative detection of nucleoside substances needs to be proposed. Summary of the Invention

[0006] The purpose of the present invention is to provide a hybrid bimetallic plasma array and a preparation method and a plasma array assisted laser desorption ionization mass spectrometry detection method and application in order to solve at least one of the above problems, so as to solve the problem that chromatography and enzyme-linked immunosorbent assay in the prior art are difficult to accurately and quantitatively detect nucleoside substances, and MALDI MS has strong background noise in the low mass region resulting in inaccurate detection, and realizes rapid and selective identification of specific molecules, and can obtain the signal intensity of specific molecules through fingerprints, has the advantages of simple operation, high sensitivity, low cost, and high detection throughput, and has the potential to be applied to complex clinical samples.

[0007] The purpose of the present invention is achieved through the following technical solutions:

[0008] The first aspect of the present invention discloses a hybrid bimetallic plasma array, which is obtained by self-assembly of positively charged noble metal nanoparticles and negatively charged noble metal nanoparticles, wherein:

[0009] The positively charged noble metal nanoparticles and the negatively charged noble metal nanoparticles are nanoparticles of different noble metals; or,

[0010] The at least positively charged noble metal nanoparticle is a dual noble metal nanoparticle; or,

[0011] The at least negatively charged noble metal nanoparticles are dual noble metal nanoparticles.

[0012] Preferably, the noble metal nanoparticles include Ag nanoparticles, Pt nanoparticles, Au nanoparticles and Pt / Au nanoparticles.

[0013] The second aspect of the present invention discloses a method for preparing the hybrid bimetallic plasma array as described above, comprising the following steps:

[0014] S1: Preparation of positively charged noble metal nanoparticles:

[0015] The metal source and the first capping agent are mixed by stirring at room temperature, and then a reducing agent is added to the mixture and the mixture is allowed to stand in the dark to obtain a suspension of positively charged noble metal nanoparticles;

[0016] S2: Preparation of negatively charged noble metal nanoparticles:

[0017] heating and stirring the metal source until boiling, adding the second capping agent to the boiling metal source and maintaining the boiling state, and then continuing to stir during natural cooling to obtain a suspension of negatively charged noble metal nanoparticles;

[0018] S3: Preparation of Plasma Array:

[0019] The negatively charged precious metal nanoparticles prepared in step S2 are dispersed in oil, and the aqueous suspension of the positively charged precious metal nanoparticles prepared in step S1 is added and shaken to self-assemble at the water-oil two-phase or oil-water-oil three-phase interface to form a hybrid bimetallic plasma array.

[0020] Preferably, the metal source includes one or both of HAuCl4 and H2PtCl6; the first capping agent includes cysteine ​​solution; the second capping agent includes sodium citrate; and the oil includes 1,2-dichloroethane and n-hexane.

[0021] Preferably, in step S1, the stirring time is 20 minutes, and the light-proof standing time is 10 minutes; in step S2, the boiling time is 10 minutes, and the stirring time during the natural cooling process is 15 minutes; in step S3, the shaking time is 30 seconds.

[0022] Preferably, the volume ratio of the oil, the negatively charged noble metal nanoparticles, and the positively charged noble metal nanoparticles is 500:400:20.

[0023] The third aspect of the present invention discloses a detection method of plasma array assisted laser desorption ionization mass spectrometry, using the hybrid bimetallic plasma array as described above as a matrix, or using a hybrid bimetallic plasma array prepared by any of the methods described above as a matrix;

[0024] The detection method comprises the following steps:

[0025] S4: Sample pretreatment:

[0026] The reaction sample was added to the extractant and vortexed, and then centrifuged after freezing, and the supernatant was collected;

[0027] S5: Sample preparation:

[0028] Preheating the target plate, transferring the plasma array onto the target plate and drying it, dropping the sample processed in step S4 onto the plasma array and drying it;

[0029] S6: Sample testing:

[0030] In matrix-assisted laser desorption ionization mass spectrometry, the sample prepared in step S5 is subjected to mass spectrometry detection in positive ion reflection mode.

[0031] Preferably, the reaction sample includes a blood sample, a biological sample, a food sample and an environmental sample; and the extractant includes methanol, acetonitrile and water in a volume ratio of 2:2:1.

[0032] Preferably, in step S4, the vortexing time is 30 seconds, the freezing treatment is freezing at -20°C for 2 hours, and the centrifugation is centrifugation at 12000 rpm for 10 minutes at 4°C; in step S5, the preheating temperature is 0-100°C.

[0033] The fourth aspect of the present invention discloses an application of any of the above-described plasma array assisted laser desorption ionization mass spectrometry detection methods in the quantitative detection of nucleoside substances.

[0034] Noble metals are promising laser desorption / ionization mass spectrometry (LDI MS) matrix materials, showing superior surface plasmon effects and high hot carrier effects, thereby improving the desorption and ionization of analytes. The present invention uses mixed dual noble metal nanoparticles to self-assemble through liquid-liquid interface or oil-water-oil three-phase interface to prepare a new type of uniform and densely arranged plasma array; the plasma array can preferentially detect specific metabolites (e.g., nucleosides) by enhancing the binding affinity between chemical groups (e.g., base ring nitrogen, exocyclic keto groups, imidazole groups, etc.) and noble metals.

[0035] Compared with the prior art, the present invention has the following beneficial effects:

[0036] The present invention provides a novel plasma array formed by self-assembly of mixed bimetallic nanomaterials, which can be used as a matrix material for matrix-assisted laser desorption ionization mass spectrometry and for quantitative detection of nucleoside substances.

[0037] The present invention aims to utilize self-assembled plasma array to assist LDI MS to preferentially and quantitatively detect nucleosides. The hybrid bimetallic plasma array combined with mass spectrometry shows a strong affinity for nucleosides.

[0038] The assay consumes only 4 μL of natural biological fluid and can achieve rapid (a few seconds) and accurate (R 2 >0.99) quantitatively.

[0039] Compared with existing methods, this method can quickly and selectively identify specific molecules, and can obtain the signal intensity of specific molecules through fingerprints; it is simple to operate, highly sensitive, low cost, and has high detection throughput, and has the potential to be applied to complex clinical samples. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 Schematic diagram of the experimental workflow for preferential metabolite detection using plasma array as matrix in laser desorption / ionization mass spectrometry (LDI-MS);

[0041] Figure 2 The results of inosine and adenosine detection in clinical samples, where (a), (b), and (c) are the standard curve of inosine detected by LDI MS, the results of LDI-MS detection of 23 samples, and the consistency comparison of the results of LDI-MS and ELSA kit detection, respectively; (d), (e), and (f) are the standard curve of adenosine detected by LDI MS, the results of LDI-MS detection of 19 samples, and the consistency comparison of the results of LDI-MS and ELSA kit detection, respectively;

[0042] Figure 3 Characterization diagrams of the plasma array (A2) prepared in Example 1, the plasma array (A1) prepared in Comparative Example 1, and the plasma array (A3) prepared in Comparative Example 2,

[0043] (a) i: SEM image of A1, ii: SEM image of A2, iii: SEM image of A3,

[0044] (b) i: When A1 is the substrate, inosine (1 mg mL -1 ), aspartic acid (1 mg mL -1 ), arginine (1 mg mL -1 ) mass spectrum intensity diagram, ii: When A2 is used as matrix, inosine (1 mg mL -1 ), aspartic acid (1 mg mL -1 ), arginine (1 mg mL -1 ) mass spectrum intensity diagram, iii: When A3 is used as matrix, inosine (1 mg mL -1 ), aspartic acid (1 mg mL -1 ), arginine (1 mg mL -1 )’s mass spectrum intensity diagram;

[0045] Figure 4 For the tendency of using A2 as matrix-assisted laser desorption / ionization mass spectrometry to detect 37 small molecules in Application Example 1;

[0046] Figure 5 This is the mass spectrum of a plasma sample detected by matrix-assisted laser desorption / ionization mass spectrometry using A2 in Application Example 1. DETAILED DESCRIPTION

[0047] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.

[0048] In the following examples, unless otherwise specified, the reagents used may be conventional commercially available products, and the methods used are well known in the art.

[0049] Example 1

[0050] Step 1: Preparation of instruments and reagents: Matrix-assisted laser desorption ionization mass spectrometry, using positive ion reflectron mode;

[0051] Step 2: Preparation of plasma array materials, including the following steps;

[0052] Step 2.1: Pt / Au NPs(-) with negative surface charge were synthesized using sodium citrate as a capping agent.

[0053] In detail, a mixed aqueous solution (50 mL, 1 mM) of HAuCl4 and H2PtCl6 (1 / 2, v / v) was heated to boiling while vigorously stirring. Then, a sodium citrate solution (5 mL, 38.8 mM) was quickly added to the mixture. After boiling for 10 minutes, the mixture solution was stirred for another 15 minutes without heating to obtain Pt / Au NPs(-).

[0054] Step 2.2: Positively charged Au NPs (+) were prepared using NaBH4 as a reducing agent and cysteamine solution as a capping agent.

[0055] In detail, 40 mL of 1.42 mM HAuCl4 was mixed with 400 μL of 213 mM cysteamine solution and stirred at room temperature for 20 min. Subsequently, 10 μL of 10 mM NaBH4 solution was added to the mixture, and the solution was kept in dark for 10 min to obtain Au NPs (+).

[0056] Step 2.3: Plasmonic arrays were prepared by self-assembly of oppositely charged noble metal nanoparticles at the liquid-liquid interface using a modified water-oil interface self-assembly method via simple electrostatic interactions.

[0057] First, 400 μL of negatively charged metal NPs (Pt / Au NPs(-)) were dispersed in 500 μL of 1,2-dichloroethane. Then, 20 μL of positively charged metal NPs (Au NPs(+) aqueous suspension) was added. The mixture was shaken vigorously for 30 seconds to form a bright nanofilm (i.e., plasmon array) at the interface between the two phases.

[0058] Step 2.4: The plasma array, denoted as A2, is used as a substrate;

[0059] Step 3: Sample pretreatment: Take 50 μL of plasma, add 150 μL of extraction agent (methanol: acetonitrile: water = 2:2:1 (v:v:v)), vortex for 30 s, place in a -20 °C refrigerator for 2 hours, centrifuge (12000 rpm, 10 min, 4 °C), and take the supernatant for use;

[0060] Step 4: Sample preparation on the target plate includes the following steps:

[0061] Step 4.1: Heat the target plate and control the temperature to 30°C;

[0062] Step 4.2: Using the plasma subarray prepared in step 2 as a matrix, transfer it to the target plate and dry it for later use;

[0063] Step 4.3: Take the sample pretreated in step 3, drop it on the plasma array, and dry it for later use;

[0064] Step 5: Perform mass spectrometry detection on the sample points dripped on the target plate;

[0065] Step 6: Analyze the mass spectrometry detection results and draw conclusions.

[0066] Comparative Example 1

[0067] The scheme of this comparative example is basically the same as that of Example 1, except that an Au plasma array, denoted as A1, is prepared, which is synthesized from Au NPs (+) and Au NPs (-).

[0068] Comparative Example 2

[0069] The scheme of this comparative example is basically the same as that of Example 1, except that a Pt plasma array, denoted as A3, is prepared, which is synthesized from Pt NPs (+) and Pt NP (-).

[0070] Characterization results:

[0071] From the scanning electron microscopy results ( Figure 3 (a) It can be seen that compared with A1 and A3, the arrangement of A2 array is more uniform and compact, and it shows the highest intensity among the three indicator molecules of inosine, aspartic acid and arginine ( Figure 3 (b)).

[0072] Figure 1 A schematic diagram of the experimental workflow for preferential metabolite detection using a plasma array as a matrix in laser desorption / ionization mass spectrometry (LDI MS) is shown in FIG. Figure 1 (a) is a schematic diagram of the preparation process of the matrix (plasma array) through liquid-liquid interface self-assembly. Figure 1 (b) Schematic diagram showing the preferential detection of specific metabolites (e.g., nucleosides) by the plasma array. Figure 1 (c) Schematic diagram showing the precise quantification of nucleosides in trace serum samples using plasma daughter array-assisted LDI MS.

[0073] Figure 2The results of LDI MS (using plasma array A2 as the matrix) are shown in the figure, taking inosine and adenosine as examples. It can be seen that the detection results of this method are basically consistent with those of the commercial kit (ELISA kit). By comparing the detection results of the two, it can be seen that the consistency is more than 98%, indicating that this method has excellent accuracy.

[0074] Application Example 1: Affinity Detection of 37 Small Molecules

[0075] Step 1: Preparation of instruments and reagents: Matrix-assisted laser desorption ionization mass spectrometry, using positive ion reflectron mode detection;

[0076] Step 2: Preparation of plasma array materials: consistent with the scheme in Example 1, namely A2;

[0077] Step 3: Preparation of 37 small molecule solutions: 1 mg mL -1 The sodium chloride solution was used as solvent, and the concentration of the solution was 1 mM;

[0078] Among them, the 37 small molecules are mainly divided into 6 categories: including nucleosides (inosine, guanosine, adenosine, cytidine, thymidine), pyrimidines (cytosine, thymine), amino acids (aspartic acid, glutamic acid, histidine, arginine, lysine, asparagine, glutamine, serine, alanine, glycine, cysteine, methionine, tyrosine, isoleucine, phenylalanine, proline, valine, leucine), carbohydrates (raffinose, glucose, cellobiose), hormones (estradiol, androstenedione, testosterone, estrone), and others (vitamin B1, niacinamide, lactic acid, ascorbic acid, cholesterol);

[0079] Step 4: Using A2 as the matrix, the mass spectrometry signal intensity of 37 small molecules (1 mM) was detected under a mass spectrometer and data analysis was performed. The results are as follows: Figure 4 . It shows a stronger preference for nucleosides.

[0080] Application Example 2: Detection of Real Plasma Samples

[0081] Step 1: Preparation of instruments and reagents: Matrix-assisted laser desorption ionization mass spectrometry, using positive ion reflectron mode detection;

[0082] Step 2: Preparation of plasma array materials: consistent with the scheme in Example 1, namely A2;

[0083] Step 3: Clinical sample pretreatment: Take 50 μL of plasma sample, add 150 μL of extraction agent (methanol: acetonitrile: water = 2:2:1, v / v / v), vortex for 30 seconds, place in a -20℃ refrigerator for 2 hours, centrifuge (12000 rpm, 15 min, 4℃), and take the supernatant for use;

[0084] Step 4: Use A2 as the matrix, transfer to the target plate and dry it, then add 2 μL of the sample in step 3. After drying at room temperature, detect the clinical plasma sample under the mass spectrometer. The mass spectrometry results are as follows: Figure 5 As shown, fragment peaks of guanosine, adenosine and inosine were observed at m / z 174.01, 180.11 and 181.01, respectively.

[0085] In some other embodiments, the matrix material is not limited to the Pt / Au alloy material, but can also be extended to the matrix materials of all applications and laser desorption ionization mass spectrometry, such as Au / Ag alloy material, Pt / Ag alloy material, etc. And the above matrix material can be prepared by a combination of different precious metal nanoparticles, such as: Pt / Au alloy material can also be prepared by Au NPs(+) and Pt NPs(-), Pt / Au NPs(+) and Au NP(-), etc.; Au / Ag alloy material can be prepared by Au NPs(+) and Ag NPs(-), Au / AgNPs(+) and Ag NPs(-), etc.; the main difference from Example 1 is that the configuration ratio is different, and the optimal ratio or the preferred ratio range is selected according to experimental optimization.

[0086] In some other embodiments, the reaction system samples can be extended to other biological samples (such as urine, sweat, saliva, pericardial fluid, etc.), food samples (such as milk), environmental samples (waste liquid, river water), etc.

[0087] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.

Claims

1. A hybrid bimetallic plasma array, It is characterized in that It is obtained by self-assembly of positively charged noble metal nanoparticles and negatively charged noble metal nanoparticles, wherein: The positively charged noble metal nanoparticles and the negatively charged noble metal nanoparticles are nanoparticles of different noble metals; or, The at least positively charged noble metal nanoparticle is a dual noble metal nanoparticle; or, The at least negatively charged noble metal nanoparticle is a dual noble metal nanoparticle; The noble metal nanoparticles include Ag nanoparticles, Pt nanoparticles, Au nanoparticles, Au / Ag nanoparticles and Pt / Au nanoparticles; The hybrid bimetallic plasma array is a uniformly and densely arranged plasma array, which can achieve preferential detection of nucleoside substances in matrix-assisted laser desorption ionization mass spectrometry by enhancing the binding affinity between chemical groups and noble metals.

2. A method for preparing the hybrid bimetallic plasma array as claimed in claim 1, It is characterized in that The steps include: S1: Preparation of positively charged noble metal nanoparticles: The metal source and the first capping agent are mixed by stirring at room temperature, and then a reducing agent is added to the mixture and the mixture is allowed to stand in the dark to obtain a suspension of positively charged noble metal nanoparticles; S2: Preparation of negatively charged noble metal nanoparticles: heating and stirring the metal source until boiling, adding the second capping agent to the boiling metal source and maintaining the boiling state, and then continuing to stir during natural cooling to obtain a suspension of negatively charged noble metal nanoparticles; S3: Preparation of Plasma Array: The negatively charged suspension of precious metal nanoparticles prepared in step S2 is dispersed in oil, and the positively charged suspension of precious metal nanoparticles prepared in step S1 is added and shaken to self-assemble at the water-oil two-phase interface or the oil-water-oil three-phase interface to form a mixed bimetallic plasma array.

3. The method for preparing a hybrid bimetallic plasma array according to claim 2, It is characterized in that The metal source includes HAuCl 4 and H 2 PtCl 6 One or two of the following: the first capping agent comprises a cysteine ​​solution; the second capping agent comprises sodium citrate; and the oil comprises 1,2-dichloroethane and n-hexane.

4. The method for preparing a hybrid bimetallic plasma array according to claim 2, It is characterized in that In step S1, the stirring time is 20 min, and the light-proof standing time is 10 min; in step S2, the boiling time is 10 min, and the stirring time during the natural cooling process is 15 min; in step S3, the shaking time is 30 s.

5. The method for preparing a hybrid bimetallic plasma array according to claim 2, It is characterized in that The volume ratio of the oil, the negatively charged precious metal nanoparticles and the positively charged precious metal nanoparticles is 500:400:

20.

6. A detection method for plasma array assisted laser desorption ionization mass spectrometry, It is characterized in that Using the hybrid bimetallic plasma array as claimed in claim 1 as a substrate, or using the hybrid bimetallic plasma array prepared by any method as claimed in claim 2 to 5 as a substrate; The detection method comprises the following steps: S4: Sample pretreatment: The reaction sample was added to the extractant and vortexed, and then centrifuged after freezing, and the supernatant was collected; S5: Sample preparation: Preheating the target plate, transferring the plasma array onto the target plate and drying it, dropping the sample processed in step S4 onto the plasma array and drying it; S6: Sample testing: In matrix-assisted laser desorption ionization mass spectrometry, the sample prepared in step S5 is subjected to mass spectrometry detection in positive ion reflection mode.

7. The detection method of plasma array assisted laser desorption ionization mass spectrometry according to claim 6, It is characterized in that The reaction samples include blood samples, biological samples, food samples and environmental samples; the extractant includes methanol, acetonitrile and water in a volume ratio of 2:2:

1.

8. The detection method of plasma array assisted laser desorption ionization mass spectrometry according to claim 6, It is characterized in that In step S4, the vortexing time is 30 s, the freezing treatment is freezing at -20°C for 2 h, and the centrifugation is centrifugation at 12000 rpm for 10 min at 4°C; in step S5, the preheating temperature is 0-100°C.

9. Use of the plasma array assisted laser desorption ionization mass spectrometry detection method as claimed in any one of claims 6 to 8 in the quantitative detection of nucleoside substances.